Ubs Group Ag Edwards Lifesciences Corp Transaction History

Ubs Group Ag

$400 Billion
Q2 2024

A detailed history of Ubs Group Ag transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Ubs Group Ag holds 1,657,890 shares of EW stock, worth $109 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

1,657,890

Previous 45,000 3584.2%

Holding current value

$109 Million

Previous $4.3 Million 3461.37%

% of portfolio

0.04%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$84.3 - $94.31 $19.9 Million - $22.2 Million	235,704 Added 16.57%	1,657,890 $153 Million
Q1 2024 May 13, 2024	BUY	$72.54 - $95.56 $216,314 - $284,959	2,982 Added 0.21%	1,422,186 $136 Million
Q4 2023 Feb 09, 2024	SELL	$61.71 - $77.76 $58.7 Million - $74 Million	-951,132 Reduced 40.13%	1,419,204 $108 Million
Q3 2023 Nov 09, 2023	BUY	$69.28 - $93.38 $20,922 - $28,200	302 Added 0.01%	2,370,336 $164 Million
Q2 2023 Aug 11, 2023	BUY	$81.41 - $94.33 $18.1 Million - $21 Million	222,623 Added 10.37%	2,370,034 $224 Million
Q1 2023 May 12, 2023	SELL	$74.26 - $84.51 $12.1 Million - $13.8 Million	-162,808 Reduced 7.05%	2,147,411 $178 Million
Q4 2022 Feb 08, 2023	SELL	$68.3 - $87.44 $3.98 Million - $5.1 Million	-58,311 Reduced 2.46%	2,310,219 $172 Million
Q3 2022 Nov 10, 2022	SELL	$82.37 - $107.29 $12 Million - $15.6 Million	-145,446 Reduced 5.79%	2,368,530 $196 Million
Q2 2022 Aug 10, 2022	BUY	$86.5 - $128.27 $1.38 Million - $2.05 Million	15,991 Added 0.64%	2,513,976 $239 Million
Q1 2022 May 16, 2022	SELL	$101.96 - $128.34 $36.9 Million - $46.5 Million	-362,168 Reduced 12.66%	2,497,985 $294 Million
Q4 2021 Feb 14, 2022	BUY	$106.37 - $130.68 $26.5 Million - $32.6 Million	249,083 Added 9.54%	2,860,153 $371 Million
Q3 2021 Nov 15, 2021	SELL	$102.91 - $122.75 $14.5 Million - $17.3 Million	-141,213 Reduced 5.13%	2,611,070 $296 Million
Q2 2021 Aug 13, 2021	BUY	$83.84 - $104.76 $15.4 Million - $19.2 Million	183,669 Added 7.15%	2,752,283 $285 Million
Q1 2021 May 12, 2021	BUY	$78.68 - $90.67 $21.4 Million - $24.6 Million	271,440 Added 11.82%	2,568,614 $215 Million
Q4 2020 Feb 11, 2021	BUY	$71.69 - $91.23 $19.3 Million - $24.6 Million	269,770 Added 13.31%	2,297,174 $210 Million
Q3 2020 Nov 12, 2020	BUY	$67.19 - $87.44 $13.2 Million - $17.2 Million	196,543 Added 10.74%	2,027,404 $162 Million
Q2 2020 Jul 31, 2020	BUY	$57.54 - $76.95 $67 Million - $89.6 Million	1,163,972 Added 174.54%	1,830,861 $127 Million
Q1 2020 May 01, 2020	SELL	$52.41 - $81.0 $2.22 Million - $3.42 Million	-42,267 Reduced 5.96%	666,889 $126 Million
Q4 2019 Feb 14, 2020	SELL	$71.7 - $82.09 $6.61 Million - $7.57 Million	-92,235 Reduced 11.51%	709,156 $165 Million
Q3 2019 Nov 14, 2019	SELL	$61.55 - $75.43 $911,555 - $1.12 Million	-14,810 Reduced 1.81%	801,391 $176 Million
Q2 2019 Aug 14, 2019	SELL	$55.74 - $64.41 $2.73 Million - $3.15 Million	-48,924 Reduced 5.66%	816,201 $151 Million
Q1 2019 May 14, 2019	BUY	$47.89 - $64.05 $2.24 Million - $2.99 Million	46,695 Added 5.71%	865,125 $166 Million
Q4 2018 Feb 14, 2019	SELL	$46.41 - $56.94 $634,239 - $778,142	-13,666 Reduced 1.64%	818,430 $125 Million
Q3 2018 Nov 14, 2018	BUY	$45.7 - $58.03 $941,374 - $1.2 Million	20,599 Added 2.54%	832,096 $145 Million
Q2 2018 Aug 14, 2018	BUY	$42.45 - $51.3 $1.56 Million - $1.89 Million	36,782 Added 4.75%	811,497 $118 Million
Q1 2018 May 15, 2018	SELL	$37.19 - $47.45 $3.12 Million - $3.99 Million	-83,987 Reduced 9.78%	774,715 $108 Million
Q4 2017 Feb 14, 2018	BUY	$33.79 - $39.39 $170,707 - $198,998	5,052 Added 0.59%	858,702 $96.8 Million
Q3 2017 Nov 14, 2017	SELL	$36.29 - $38.83 $2.11 Million - $2.26 Million	-58,111 Reduced 6.37%	853,650 $93.3 Million
Q2 2017 Aug 14, 2017	BUY	N/A	38,068 Added 4.36%	911,761 $108 Million
Q1 2017 Nov 14, 2017	BUY	N/A	873,693	873,693 $82.2 Million

Others Institutions Holding EW

# of Institutions

1,417

Shares Held

469M

Call Options Held

2.44M

Put Options Held

2.65M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account